SGEN Snapshot
Seagen Inc., a biotechnology company, develops and markets cancer treatment therapies in the United States and internationally. The company is headquartered in Bothell, Washington.
VALUATION DATA
Market Capitalization$23,824,306,000
Price to Sales13.65
Earnings per Share$-1.8380
PE RatioNone
PRICE DATA
Most Recent Close$133.0600
52 Week High$199
52 Week Low$129.61
50-Day Moving Average$160.49
200-Day Moving Average$156.72
All data are from Alpha Vantage as of today. For more infomation on SGEN see Stock Dividend, Valuation, Price and Financial Data for Investors